Loading company…
Thrasos Therapeutics Inc. is a Montreal, Canada biotech developing targeted therapies for severe organ failure, mainly kidney disease.
Thrasos Therapeutics Inc. researches and develops targeted therapies to prevent and treat severe organ failure, with a principal focus on kidney disease. Established in Montreal, Canada, the company is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in